Optum is pleased to release the latest edition of Clinical Info, encompassing noteworthy changes to medications and guidelines affecting the workers’ compensation industry. Within this edition you will read about the ongoing efforts to curb opioid analgesic misuse and abuse and the use of adjuvant medications for chronic pain.
- New drug approvals
- Tentative new drug approvals
- New brand and generic product launches
- Safety communications, warnings and recalls.
This is a sponsored post from WorkCompWire marketing partner Optum.